PublishedSeptember 5, 2023 Category Partner News Insmed Announces Positive Topline Results From Phase 3 ARISE Study of ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with NTM Lung Disease Caused by MAC
PublishedAugust 30, 2023 Category PARI Publications Transient Aerosol Measurements: Assessing the eFlow Nebulizer Aerosol Bolus.
PublishedJune 27, 2023 Category Partner News Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
PublishedJune 7, 2023 Category Publications Large-eddy simulation, convective instability, and modal causality of coaxial supersonic air–water jets considering a swirl effect.
PublishedMay 2, 2023 Category Partner News Zambon Completes Enrollment in Phase 3 Clinical Development Program Evaluating Liposomal Cyclosporine A for Inhalation (L-CsA-i) in Patients with Bronchiolitis Obliterans Syndrome (BOS)